Answers are grounded in this paper and cite their sources.
There is an increasing body of evidence demonstrating that elevated growth signaling in breast cancer cells can promote forms of endocrine resistance in either an estrogen receptor-dependent or -independent manner. The current article reviews what is known about such growth factor signaling networks and resistance to estrogen withdrawal and considers the many novel therapeutic opportunities that stem from this knowledge.
No takes yet. Share an insight, caveat, or question.
Nicholson et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: